ED Coding & Reimbursement Alert - 2010 Issue 3
INDUSTRY NEWS: J&J PowerPoint Kickback Case Lesson: Keep Those Intentions Clean!
Subscribe or sign in to view the full article.
Article Overview
This article covers a federal False Claims Act and fraud-and-abuse matter involving pharmaceutical-company payments, internal financial presentation materials, and the compliance risks that can arise when financial documents are reviewed in connection with referral-related business relationships. It is aimed at providers, facilities, compliance professionals, and others who evaluate compensation arrangements, supporting documentation, and financial presentations for potential legal and reputational risk.
Why This Topic Matters
It highlights how ordinary-looking financial materials can be scrutinized in enforcement actions and why organizations involved in referral-sensitive relationships should maintain clear, supportable documentation and careful review practices.
What You Will Learn
- Why financial presentations can draw regulatory scrutiny in referral-sensitive business relationships
- Common compliance concerns raised by compensation and service arrangements in healthcare
- How providers and facilities can think about documenting and reviewing financial materials
- General risk areas involving pharmaceutical company relationships and enforcement activity
Who Should Read This
- Healthcare providers
- Facility administrators
- Compliance officers
- Revenue cycle professionals
- Healthcare legal and audit teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com